Who owns REGENERON PHARMACEUTICALS, INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of REGN from SEC Form 13F filings across 1,333 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 1,333 institutions disclosed 91.4M shares of REGENERON PHARMACEUTICALS, INC. worth $57.08B — about 88.9% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
1,333
13F holders
$57.08B
value, 2026 filers
88.9%
of shares outstanding (91.4M sh)
144
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of REGN's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 9.1M | $5.68B | 0.1% | 8.9% | +1.9% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 6.6M | $4.13B | 0.1% | 6.4% | -0.4% |
| 3 | Dodge & Cox | 4.9M | $3.04B | 1.6% | 4.7% | +9.3% |
| 4 | STATE STREET CORP | 4.8M | $3.01B | 0.1% | 4.7% | +3.6% |
| 5 | Invesco Ltd. | 3.9M | $2.46B | 0.2% | 3.8% | +128.5% |
| 6 | JPMORGAN CHASE & CO | 3.8M | $2.38B | 0.1% | 3.7% | -12.5% |
| 7 | VANGUARD PORTFOLIO MANAGEMENT LLC | 3.2M | $1.98B | 0.1% | 3.1% | +84.5% |
| 8 | FRANKLIN RESOURCES INC | 2.8M | $1.73B | 0.4% | 2.7% | +1.8% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 2.6M | $1.63B | 0.1% | 2.6% | +0.7% |
| 10 | Nuveen, LLC | 2.0M | $1.26B | 0.3% | 2% | -2.2% |
| 11 | LOOMIS SAYLES & CO L P | 1.9M | $1.16B | 1.5% | 1.8% | -2.8% |
| 12 | PRICE T ROWE ASSOCIATES INC /MD/ | 1.5M | $953.8M | 0.1% | 1.5% | -29.8% |
| 13 | MORGAN STANLEY | 1.4M | $871.5M | 0.0% | 1.4% | +5.9% |
| 14 | BANK OF AMERICA CORP /DE/ | 1.3M | $805.0M | 0.1% | 1.3% | +8.5% |
| 15 | WELLINGTON MANAGEMENT GROUP LLP | 1.3M | $792.0M | 0.1% | 1.2% | -30.9% |
| 16 | NORGES BANKNEW | 1.2M | $731.3M | 0.1% | 1.1% | new |
| 17 | GOLDMAN SACHS GROUP INC | 1.2M | $725.3M | 0.1% | 1.1% | -10.6% |
| 18 | AQR CAPITAL MANAGEMENT LLC | 1.1M | $702.2M | 0.2% | 1.1% | -8.5% |
| 19 | Amundi | 1.0M | $632.0M | 0.2% | 1% | +0.4% |
| 20 | NORTHERN TRUST CORP | 916,467 | $571.5M | 0.1% | 0.9% | -2.7% |
| 21 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 846,306 | $527.7M | 0.1% | 0.8% | +5.2% |
| 22 | FMR LLC | 831,964 | $518.8M | 0.0% | 0.8% | -45.2% |
| 23 | Capital World Investors | 814,925 | $508.1M | 0.1% | 0.8% | -42.6% |
| 24 | Legal & General Group Plc | 759,971 | $473.9M | 0.1% | 0.7% | +3.8% |
| 25 | Bank of New York Mellon Corp | 758,492 | $473.0M | 0.1% | 0.7% | -0.9% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.